Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not: The TRIUMPH Study

William Harris, K. F. Kennedy, T. M. Maddox, S. Kutty, J. A. Spertus

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The utility of fish oil supplements (FOS) in patients who survive an acute myocardial infarction (MI) remains controversial, with randomized trials showing less benefit than observational studies would suggest. The differences in the characteristics of MI patients who use FOS in routine clinical care are unknown but may help explain this discrepancy. We used data from a 24-site registry study in which extensive information was available on 4340 MI patients at admission and 1, 6, and 12 months postdischarge. After excluding those using FOS at admission (n = 651), those who died before the 1-month follow-up visit (n = 63), and those with missing data at 1 month (n = 1228), 2398 remained. Of them, 377 (16%) started FOS within 1 month of their MI. We analyzed 53 patient characteristics associated with FOS use. We observed differences ( P <.001) in 20 demographic, socioeconomic, treatment, disease severity, and health status domains. The FOS users were more likely than nonusers to be white, married, financially secure, highly educated, and eating fish. They also had a higher ejection fraction at discharge, were more likely to have had in-hospital percutaneous coronary interventions, and were more likely to have participated in cardiac rehabilitation programs. The FOS users were less likely to have a history of diabetes, alcohol abuse, stroke, MI, and angina. In conclusion, post-MI patients who initiate FOS within 1 month of discharge in routine clinical practice differ substantially from those who do not. These differences are strongly associated with a better post-MI prognosis and may illuminate several sources of unmeasured confounding in observational studies.

Original languageEnglish (US)
Pages (from-to)65-71
Number of pages7
JournalNutrition Research
Volume36
Issue number1
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Fish Oils
Myocardial Infarction
Observational Studies
Patient Admission
Percutaneous Coronary Intervention
Alcoholism
Health Status
Registries
Fishes
Eating
Stroke
Demography

Keywords

  • Confounding
  • Fish oil
  • Human
  • Myocardial infarction
  • Nutritional supplements
  • Omega-3 fatty acids

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not : The TRIUMPH Study. / Harris, William; Kennedy, K. F.; Maddox, T. M.; Kutty, S.; Spertus, J. A.

In: Nutrition Research, Vol. 36, No. 1, 01.01.2016, p. 65-71.

Research output: Contribution to journalArticle

Harris, William ; Kennedy, K. F. ; Maddox, T. M. ; Kutty, S. ; Spertus, J. A. / Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not : The TRIUMPH Study. In: Nutrition Research. 2016 ; Vol. 36, No. 1. pp. 65-71.
@article{4c800b71c4c3475796d890561387f245,
title = "Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not: The TRIUMPH Study",
abstract = "The utility of fish oil supplements (FOS) in patients who survive an acute myocardial infarction (MI) remains controversial, with randomized trials showing less benefit than observational studies would suggest. The differences in the characteristics of MI patients who use FOS in routine clinical care are unknown but may help explain this discrepancy. We used data from a 24-site registry study in which extensive information was available on 4340 MI patients at admission and 1, 6, and 12 months postdischarge. After excluding those using FOS at admission (n = 651), those who died before the 1-month follow-up visit (n = 63), and those with missing data at 1 month (n = 1228), 2398 remained. Of them, 377 (16{\%}) started FOS within 1 month of their MI. We analyzed 53 patient characteristics associated with FOS use. We observed differences ( P <.001) in 20 demographic, socioeconomic, treatment, disease severity, and health status domains. The FOS users were more likely than nonusers to be white, married, financially secure, highly educated, and eating fish. They also had a higher ejection fraction at discharge, were more likely to have had in-hospital percutaneous coronary interventions, and were more likely to have participated in cardiac rehabilitation programs. The FOS users were less likely to have a history of diabetes, alcohol abuse, stroke, MI, and angina. In conclusion, post-MI patients who initiate FOS within 1 month of discharge in routine clinical practice differ substantially from those who do not. These differences are strongly associated with a better post-MI prognosis and may illuminate several sources of unmeasured confounding in observational studies.",
keywords = "Confounding, Fish oil, Human, Myocardial infarction, Nutritional supplements, Omega-3 fatty acids",
author = "William Harris and Kennedy, {K. F.} and Maddox, {T. M.} and S. Kutty and Spertus, {J. A.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.nutres.2015.11.006",
language = "English (US)",
volume = "36",
pages = "65--71",
journal = "Nutrition Research",
issn = "0271-5317",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Multiple differences between patients who initiate fish oil supplementation post-myocardial infarction and those who do not

T2 - The TRIUMPH Study

AU - Harris, William

AU - Kennedy, K. F.

AU - Maddox, T. M.

AU - Kutty, S.

AU - Spertus, J. A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The utility of fish oil supplements (FOS) in patients who survive an acute myocardial infarction (MI) remains controversial, with randomized trials showing less benefit than observational studies would suggest. The differences in the characteristics of MI patients who use FOS in routine clinical care are unknown but may help explain this discrepancy. We used data from a 24-site registry study in which extensive information was available on 4340 MI patients at admission and 1, 6, and 12 months postdischarge. After excluding those using FOS at admission (n = 651), those who died before the 1-month follow-up visit (n = 63), and those with missing data at 1 month (n = 1228), 2398 remained. Of them, 377 (16%) started FOS within 1 month of their MI. We analyzed 53 patient characteristics associated with FOS use. We observed differences ( P <.001) in 20 demographic, socioeconomic, treatment, disease severity, and health status domains. The FOS users were more likely than nonusers to be white, married, financially secure, highly educated, and eating fish. They also had a higher ejection fraction at discharge, were more likely to have had in-hospital percutaneous coronary interventions, and were more likely to have participated in cardiac rehabilitation programs. The FOS users were less likely to have a history of diabetes, alcohol abuse, stroke, MI, and angina. In conclusion, post-MI patients who initiate FOS within 1 month of discharge in routine clinical practice differ substantially from those who do not. These differences are strongly associated with a better post-MI prognosis and may illuminate several sources of unmeasured confounding in observational studies.

AB - The utility of fish oil supplements (FOS) in patients who survive an acute myocardial infarction (MI) remains controversial, with randomized trials showing less benefit than observational studies would suggest. The differences in the characteristics of MI patients who use FOS in routine clinical care are unknown but may help explain this discrepancy. We used data from a 24-site registry study in which extensive information was available on 4340 MI patients at admission and 1, 6, and 12 months postdischarge. After excluding those using FOS at admission (n = 651), those who died before the 1-month follow-up visit (n = 63), and those with missing data at 1 month (n = 1228), 2398 remained. Of them, 377 (16%) started FOS within 1 month of their MI. We analyzed 53 patient characteristics associated with FOS use. We observed differences ( P <.001) in 20 demographic, socioeconomic, treatment, disease severity, and health status domains. The FOS users were more likely than nonusers to be white, married, financially secure, highly educated, and eating fish. They also had a higher ejection fraction at discharge, were more likely to have had in-hospital percutaneous coronary interventions, and were more likely to have participated in cardiac rehabilitation programs. The FOS users were less likely to have a history of diabetes, alcohol abuse, stroke, MI, and angina. In conclusion, post-MI patients who initiate FOS within 1 month of discharge in routine clinical practice differ substantially from those who do not. These differences are strongly associated with a better post-MI prognosis and may illuminate several sources of unmeasured confounding in observational studies.

KW - Confounding

KW - Fish oil

KW - Human

KW - Myocardial infarction

KW - Nutritional supplements

KW - Omega-3 fatty acids

UR - http://www.scopus.com/inward/record.url?scp=84953322233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953322233&partnerID=8YFLogxK

U2 - 10.1016/j.nutres.2015.11.006

DO - 10.1016/j.nutres.2015.11.006

M3 - Article

C2 - 26773782

AN - SCOPUS:84953322233

VL - 36

SP - 65

EP - 71

JO - Nutrition Research

JF - Nutrition Research

SN - 0271-5317

IS - 1

ER -